ATOSSA THERAPEUTICS INC
ATOS · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $2.60
- Today’s Low
- $2.30
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.44
- Previous Close
- $2.38
- Volume
- 81.41K
- Market Cap
- $23.83M
- P/E Ratio
- --
- EPS
- $-4.34
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 448 NW MARKET STREET, SEATTLE, WA, UNITED STATES, 98107
- Country
- US
- Listing Date
- 2012-11-08
- Fiscal Year End
- December
- Shares Outstanding
- 9.97M
- CIK
- 0001488039
- Website
- atossatherapeutics.com
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$8.69M
2026-03-31
$9.86M
2025-12-31
$11.43M
2025-09-30
$9.24M
Net Income
2026-06-30
-$8.49M
2026-03-31
-$9.58M
2025-12-31
-$10.93M
2025-09-30
-$8.69M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.95
2026-03-31
$-1.11
2025-12-31
$-1.34
2025-09-30
$-1.05
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$8.48M
2026-03-31
-$9.58M
2025-12-31
-$10.93M
2025-09-30
-$8.68M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $8.69M | $9.86M | $11.43M | $9.24M |
| Net Income | -$8.49M | -$9.58M | -$10.93M | -$8.69M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.95 | $-1.11 | $-1.34 | $-1.05 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$8.48M | -$9.58M | -$10.93M | -$8.68M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.